AI Verdict
PBSV has stronger fundamentals based on our AI analysis.
PCOK vs PBSV Fundamental Comparison
| Metric | PCOK | PBSV |
|---|---|---|
| Revenue | $92.1M | $2.3M |
| Net Income | $-244.1M | $32,860.0 |
| Net Margin | -265.2% | 1.4% |
| ROE | N/A | 0.3% |
| ROA | -27.6% | 0.2% |
| Current Ratio | N/A | 4.03x |
| Debt/Equity | N/A | 0.00x |
| EPS | $-2.37 | $0.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PCOK vs PBSV: Frequently Asked Questions
Is PCOK or PBSV a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), PBSV has stronger fundamentals. PCOK is rated STRONG SELL (92% confidence) while PBSV is rated SELL (78% confidence). This is not investment advice.
How does PCOK compare to PBSV fundamentally?
Pacific Oak Strategic Opportunity REIT, Inc. has ROE of N/A vs Pharma-Bio Serv, Inc.'s 0.3%. Net margins are -265.2% vs 1.4% respectively.
Which stock pays higher dividends, PCOK or PBSV?
PCOK has a dividend yield of N/A or no dividend while PBSV has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PCOK or PBSV for long term?
For long-term investing, consider that PCOK has STRONG SELL rating with 92% confidence, while PBSV has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PCOK vs PBSV?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PCOK vs PBSV, the AI consensus favors PBSV based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.